Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Janux Therapeutics (JANX) Interest Expenses (2020)

Janux Therapeutics (JANX) has disclosed Interest Expenses for 1 consecutive years, with $109000.0 as the latest value for Q2 2020.

  • Quarterly Interest Expenses changed N/A to $109000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $109000.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $206000.0 for FY2020, N/A changed from the prior year.
  • Interest Expenses for Q2 2020 was $109000.0 at Janux Therapeutics.
  • The five-year high for Interest Expenses was $109000.0 in Q2 2020, with the low at $109000.0 in Q2 2020.